Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Purpose: To assess the effectiveness and tolerability of a new latanoprost 0.005% benzalkonium chloride (BAK)-free nanoemulsion. Methods: A nonrandomized multicenter study was conducted between January 2017 and October 2017 in 15 ophthalmological clinics from Argentina. This study enrolled 113 p...

Full description

Bibliographic Details
Main Authors: Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa, Mar?a Silvia Passerini
Format: Article
Language:English
Published: Mary Ann Liebert 2021-01-01
Series:Re:GEN Open
Subjects:
Latanoprost
BAK-free
nanoemulsion
glaucoma
ocular surface
Online Access:https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0018

Internet

https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0018

Similar Items